Bruker Daltonics

Jeffery Zonderman, senior vice-president at Bruker Applied MS, joined Technology Networks for an interview at this year's American Society for Mass Spectrometry event.

In this webinar, our expert speaker will discuss how HPLC-MS can detect a wide range of allergens in a single run, reducing the time and effort involved in food analysis.

Hear about the latest advancements in translational proteomics and metabolomics. From the molecular mechanisms of disease pathology to the latest technological developments in diagnostics and treatment.

MALDI mass spectrometry imaging has emerged as a powerful technology platform for spatially resolved analysis and visualization of a wide range of molecules – including drugs, metabolites, peptides and more – in pharmaceutical R&D, clinical research and basic science. Advances in MALDI workflows are making the technique more accessible.
In this webinar, our speaker will discuss how a new MALDI workflow can be used to analyze lipids in degenerative disease and Alzheimer’s models, contextualizing lipid distribution by enabling comparison to multiple protein markers.
He’ll also highlight how the new workflow can be applied to the study of tumor subtypes and the tumor microenvironment.

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue imaging.

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells and subcellular organelles.

Bruker Corporation officially opened its new production facility in Bremen – one of Germany’s major science hubs – last week. Technology Networks visited the facility to learn about its low carbon footprint and how it will support Bruker's commitment to innovation and collaboration.

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.

Human blood plasma contains thousands of distinct lipid species. These lipids can provide new insights into health and disease, with lipidomic profiling revealing new biomarkers for various conditions and being used to monitor the efficacy of treatments.

In this eBook, expert insights reveal how to detect these elusive targets with TIMS and PASEF for unmatched sensitivity, precise precursor control and deeper MHC insights.